Chromosome translocation in multiple myeloma results in aberrant MAFB expression [11, 20], and miR-223 suppresses nasopharyngeal carcinoma cell proliferation and migration by targeting MAFB [14]. The gene discussed is MAFB; the disease is nasopharyngeal carcinoma.